Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma
Roberto Aiolfi, Giovanni Sitia Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy Abstract: Platelets, the chief effectors of vascular homeostasis, have been identified as important players in the pathogenesis of both acute and chronic l...
Main Authors: | Aiolfi R, Sitia G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-11-01
|
Series: | Journal of Hepatocellular Carcinoma |
Subjects: | |
Online Access: | https://www.dovepress.com/emerging-role-of-dual-antiplatelet-therapy-in-the-prevention-of-hepati-peer-reviewed-article-JHC |
Similar Items
-
HPA-1a/1b could be considered a molecular predictor of poor prognosis in chronic hepatitis C
by: Rejane Maria Tommasini Grotto, et al. -
Decreased granzyme-B expression in CD11c+CD8+ T cells associated with disease progression in patients with HBV-related hepatocellular carcinoma
by: Lin Gao, et al.
Published: (2023-01-01) -
Cure in Chronic Hepatitis C! Does it Prevent the Risk of Hepatocellular Carcinoma?
by: Mustafa Kemal ÇELEN, et al.
Published: (2018-06-01) -
Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
by: Xinhe Zhang, et al.
Published: (2021-09-01) -
Hepatitis B Virus-Associated Hepatocellular Carcinoma
by: Giacomo Emanuele Maria Rizzo, et al.
Published: (2022-05-01)